DexCom holds the cleaner structural position, with the lead spread across profitability and stability. AstraZeneca still has the edge on stability, which keeps the comparison from looking entirely one-sided. In the market, AstraZeneca carries the stronger setup — intact trend against DexCom's broken trend. That leaves a split case: the structural lead stays with DexCom, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels.
The lead is spread across profitability and valuation, rather than sitting in one isolated gap. The overall score gap is 20 points in favour of DexCom, Inc..
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
This level of similarity points to a meaningful structural match, though not a tight one.
The match is driven mainly by capital structure and recent revenue growth.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
DexCom, Inc. looks stronger both structurally and on relative valuation.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Capital efficiency adds support, with a 20.6-point ROIC advantage.
Stability still tilts materially toward AstraZeneca PLC, which stops the result from looking dominant across the whole profile.
The profitability edge is decisive, but stability still pushes back — the result holds, but not without a real counterweight.
Break down the AZN.L vs DXCM comparison across all dimensions with the full interactive tool.
Explore how AZN.L and DXCM each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.